Hepatology Society Revises Hep C Treatment Guidelines; Looking to Future Research for Non-Responders to IFN-Free Treatment

The Japan Society of Hepatology (JSH) has announced revised guidelines on the treatment of hepatitis C. The revision was prompted by a number of developments including the fact that the dual oral interferon (IFN)-free treatments Erelsa (elbasvir) and Grazyna (grazoprevir)...read more